Physician profile
Maki Jerden
NPI 1063476851
$6,326.51
in general payments reported to CMS, 2019-2025
11 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.97 · 2023: $649 · 2024: $4,055 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,578 · Travel and Lodging: $2,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,577.59 |
| Travel and Lodging | $2,729.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,599.25 | 2023-2024 | Procuity, Prevalon |
| Solventum Corporation | $1,318.78 | 2024-2025 | Prevena, V.A.C. Granufoam, V.A.C. Simplace |
| Urgo Medical North America, LLC | $930.92 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Mimedx Group, INC. | $491.61 | 2024-2025 | |
| Medline Industries LP | $388.47 | 2023-2025 | Medline |
| Kci USA, INC. | $232.91 | 2022-2023 | Activ.A.C., V.A.C.Instill, Prevena |
| Smith+Nephew, INC. | $196.79 | 2023-2025 | Collagenase Santyl |
| Kerecis Limited | $61.09 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hollister Incorporated | $51.23 | 2023 | Premier, New Image, Adapt |
| Coloplast Corp | $34.12 | 2023 | Sensura Mio |
| Convatec INC. | $21.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maki Jerden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.